{"count": 4, "results": [{"_id": "27389298", "pmid": 27389298, "title": "Simvastatin and cerebral cavernous malformations (Re: Reinhard et al., 2016).", "journal": "J Neurol Sci", "authors": ["Eisa-Beygi S"], "date": "2016-10-15T00:00:00Z", "doi": "10.1016/j.jns.2016.06.064", "meta_date_publication": "2016 Oct 15", "meta_volume": "369", "meta_issue": "", "meta_pages": "391", "score": 50088.05, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @<m>DISEASE_Hemangioma_Cavernous_Central_Nervous_System</m> @DISEASE_MESH:D020786 @@@cerebral cavernous malformations@@@ (Re: Reinhard et al., 2016).", "citations": {"NLM": "Eisa-Beygi S. Simvastatin and cerebral cavernous malformations (Re: Reinhard et al., 2016). J Neurol Sci. 2016 Oct 15;369():391. PMID: 27389298", "BibTeX": "@article{27389298, title={Simvastatin and cerebral cavernous malformations (Re: Reinhard et al., 2016).}, author={Eisa-Beygi S}, journal={J Neurol Sci}, volume={369}, pages={391}}"}}, {"_id": "27879448", "pmid": 27879448, "title": "RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.", "journal": "Stroke", "authors": ["Shenkar R", "Shi C", "Austin C", "Moore T", "Lightle R", "Cao Y", "Zhang L", "Wu M", "Zeineddine HA", "Girard R", "McDonald DA", "Rorrer A", "Gallione C", "Pytel P", "Liao JK", "Marchuk DA", "Awad IA"], "date": "2017-01-01T00:00:00Z", "doi": "10.1161/STROKEAHA.116.015013", "meta_date_publication": "2017 Jan", "meta_volume": "48", "meta_issue": "1", "meta_pages": "187-194", "score": 50071.04, "text_hl": "RhoA Kinase Inhibition With @CHEMICAL_fasudil @CHEMICAL_MESH:C049347 @@@Fasudil@@@ Versus @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in @SPECIES_10090 @@@Murine@@@ Models of @<m>DISEASE_Hemangioma_Cavernous_Central_Nervous_System</m> @DISEASE_MESH:D020786 @@@Cerebral Cavernous Malformations@@@.", "citations": {"NLM": "Shenkar R, Shi C, Austin C, Moore T, Lightle R, Cao Y, Zhang L, Wu M, Zeineddine HA, Girard R, McDonald DA, Rorrer A, Gallione C, Pytel P, Liao JK, Marchuk DA, Awad IA. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 Jan;48(1):187-194. PMID: 27879448", "BibTeX": "@article{27879448, title={RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.}, author={Shenkar R and Shi C and Austin C and Moore T and Lightle R and Cao Y and Zhang L and Wu M and Zeineddine HA and Girard R and McDonald DA and Rorrer A and Gallione C and Pytel P and Liao JK and Marchuk DA and Awad IA}, journal={Stroke}, volume={48}, number={1}, pages={187-194}}"}}, {"_id": "20809760", "pmid": 20809760, "title": "The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications.", "journal": "Neurosurg Focus", "authors": ["Krisht KM", "Whitehead KJ", "Niazi T", "Couldwell WT"], "date": "2010-09-01T00:00:00Z", "doi": "10.3171/2010.6.FOCUS10135", "meta_date_publication": "2010 Sep", "meta_volume": "29", "meta_issue": "3", "meta_pages": "E2", "score": 50066.69, "text_hl": "Close focus is directed at @SPECIES_10090 @@@mice@@@ model studies involving the @GENE_CCM2 @GENE_216527 @@@Ccm2@@@ gene product signaling pathway, revealing an important role for the use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or other @GENE_RHOA @GENE_11848 @@@RhoA@@@ inhibitors as a therapeutic modality in the treatment of @<m>DISEASE_Hemangioma_Cavernous_Central_Nervous_System</m> @DISEASE_MESH:D020786 @@@CCM@@@. ", "citations": {"NLM": "Krisht KM, Whitehead KJ, Niazi T, Couldwell WT. The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications. Neurosurg Focus. 2010 Sep;29(3):E2. PMID: 20809760", "BibTeX": "@article{20809760, title={The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications.}, author={Krisht KM and Whitehead KJ and Niazi T and Couldwell WT}, journal={Neurosurg Focus}, volume={29}, number={3}, pages={E2}}"}}, {"_id": "23817226", "pmid": 23817226, "title": "Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.", "journal": "Cell Physiol Biochem", "authors": ["Wei YM", "Li X", "Xu M", "Abais JM", "Chen Y", "Riebling CR", "Boini KM", "Li PL", "Zhang Y"], "date": "2013-01-01T00:00:00Z", "doi": "10.1159/000350111", "meta_date_publication": "2013", "meta_volume": "31", "meta_issue": "6", "meta_pages": "925-37", "score": 50053.562, "text_hl": "However, this inhibitory effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Hemangioma_Cavernous_Central_Nervous_System</m> @DISEASE_MESH:D020786 @@@CAM@@@ proliferation was blocked by by autophagy inhibitor @CHEMICAL_3_methyladenine @CHEMICAL_MESH:C025946 @@@3-methyladenine@@@ or silencing of @GENE_ATG7 @GENE_74244 @@@Atg7@@@ genes. ", "citations": {"NLM": "Wei YM, Li X, Xu M, Abais JM, Chen Y, Riebling CR, Boini KM, Li PL, Zhang Y. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem. 2013;31(6):925-37. PMID: 23817226", "BibTeX": "@article{23817226, title={Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.}, author={Wei YM and Li X and Xu M and Abais JM and Chen Y and Riebling CR and Boini KM and Li PL and Zhang Y}, journal={Cell Physiol Biochem}, volume={31}, number={6}, pages={925-37}}"}}]}